1. Market Research
  2. > Pharmaceutical Market Trends

MSL-KOL Engagement: Optimal Reach and Response Under New Rules

  • July 2015
  • 63 pages
  • Firstword Pharma
Report ID: 3153879

Summary

Table of Contents




Delivering optimal MSL performance in terms of building strong KOL relationships remains a formidable challenge as regulations and compliance requirements continue to evolve across the US and Europe. More stringent rules that govern MSL-KOL interaction are barriers that MSL directors and managers must overcome if they are to grow value in their MSL teams.

FirstWord’s latest report, MSL-KOL Engagement: Optimal Reach and Response Under New Rules, provides the most current insight from leading subject experts familiar with the challenges MSLs face today. Learn from their approach to tackling the issues and about the solutions they have deployed to stay ahead. Benchmark your MSL-KOL engagement strategies, policies, processes and systems against leading pharma companies







Get Answers to Key Questions



How has increased regulation changed the MSL-KOL dynamic?
How can the knowledge and experience of US MSLs benefit European MSLs, and vice versa?
Why are some pharma companies aiming for a consistent approach to MSL compliance management despite differences in rules between countries?
How is the evolving regulatory environment changing the skill-set and training MSLs need?
How are companies tracking and recording MSL-KOL interaction data?
How can the increased administrative burden on MSLs be reduced so they have more time to spend with KOLs?



Key Benefits

Understand the critical success factors for MSL-KOL engagement in an environment of increased scrutiny
Learn how different companies are handling the increased burden of MSL compliance and accountability
Gain knowledge on how varying rules across the US and Europe are driving MSL compliance decisions at a global level
Understand what new skills, knowledge and training MSLs are needed to excel in an evolving regulatory landscape
Learn how MSLs are helping KOLs manage the increased complexity that transparency brings to their relationship with pharma
Understand the impact of differing regulations on MSL-KOL interactions in the US and key European markets
Evaluate how disclosure rules have affected fair market value compensation
Learn how companies record and track data required under new rules



Insight and Analysis Sources

Get insights from leading pharma companies and experts including

UCB
Shire
Roche
Daiichi Sankyo
Scientific Advantage
Arx research
Philips Healthcare
A mid-sized European pharma company
Cubist International



Who Should Read This Report
This report will benefit anyone with a professional interest in the impact of new transparency regulations, especially:

Pharma companies looking to benchmark against competitors

Managers of MSLs

Medical Affairs Directors and their teams

Regulatory and compliance teams

Smaller and mid-size pharma companies looking to benefit from the learnings of better-resourced leading global companies



Methodology


Primary research from in-depth telephone interviews with medical affairs professionals from within the pharmaceutical industry and independent consultants. Supporting secondary research, mainly from publicly-available sources of information. Contributors were selected on the basis of their knowledge, experience and expertise.






About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...

Tumor Markers Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities

  • $ 52400
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.